View in EDS HTML Full Text PDF Full Text

Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in Adults.

Saved in:
Bibliographic Details
Title: Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in Adults.
Authors: Leroux-Roels G; Center for Vaccinology (CEVAC), Ghent University and University Hospital, 9000 Ghent, Belgium., Atmar RL; Departments of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Cramer JP; Clinical Development, Takeda Pharmaceuticals International AG, Farman Strasse 11, Opfikon, 8152 Zurich, Switzerland.; Clinical Development, Coalition for Epidemic Preparedness Innovations (CEPI), Gibbs Building, 215 Euston Road, London NW1 2BE, UK., Escudero I; Clinical Development, Takeda Pharmaceuticals International AG, Farman Strasse 11, Opfikon, 8152 Zurich, Switzerland.; Clinical Development, Takeda Vaccines, 75 Sidney St., Cambridge, MA 02139, USA., Borkowski A; Clinical Development, Takeda Pharmaceuticals International AG, Farman Strasse 11, Opfikon, 8152 Zurich, Switzerland.; HilleVax AG, Boulevard Lilienthal 42, Opfikon, 8152 Zurich, Switzerland.
Source: Vaccines [Vaccines (Basel)] 2025 Jan 17; Vol. 13 (1). Date of Electronic Publication: 2025 Jan 17.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39852862
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in Adults.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Leroux-Roels+G%22">Leroux-Roels G</searchLink>; Center for Vaccinology (CEVAC), Ghent University and University Hospital, 9000 Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Atmar+RL%22">Atmar RL</searchLink>; Departments of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Cramer+JP%22">Cramer JP</searchLink>; Clinical Development, Takeda Pharmaceuticals International AG, Farman Strasse 11, Opfikon, 8152 Zurich, Switzerland.; Clinical Development, Coalition for Epidemic Preparedness Innovations (CEPI), Gibbs Building, 215 Euston Road, London NW1 2BE, UK.<br /><searchLink fieldCode="AU" term="%22Escudero+I%22">Escudero I</searchLink>; Clinical Development, Takeda Pharmaceuticals International AG, Farman Strasse 11, Opfikon, 8152 Zurich, Switzerland.; Clinical Development, Takeda Vaccines, 75 Sidney St., Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Borkowski+A%22">Borkowski A</searchLink>; Clinical Development, Takeda Pharmaceuticals International AG, Farman Strasse 11, Opfikon, 8152 Zurich, Switzerland.; HilleVax AG, Boulevard Lilienthal 42, Opfikon, 8152 Zurich, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101629355%22">Vaccines</searchLink> [Vaccines (Basel)] 2025 Jan 17; Vol. 13 (1). <i>Date of Electronic Publication: </i>2025 Jan 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101629355 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2076-393X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222076393X%22">2076393X </searchLink><i>NLM ISO Abbreviation: </i>Vaccines (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39852862
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/vaccines13010082
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in Adults.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Leroux-Roels G
      – PersonEntity:
          Name:
            NameFull: Atmar RL
      – PersonEntity:
          Name:
            NameFull: Cramer JP
      – PersonEntity:
          Name:
            NameFull: Escudero I
      – PersonEntity:
          Name:
            NameFull: Borkowski A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 01
              Text: 2025 Jan 17
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2076-393X
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Vaccines
              Type: main
ResultId 1